Compare GCT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GCT | NVCR |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2022 | 2015 |
| Metric | GCT | NVCR |
|---|---|---|
| Price | $40.06 | $12.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $24.00 | ★ $28.42 |
| AVG Volume (30 Days) | 604.7K | ★ 1.8M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.32 | N/A |
| EPS | ★ 3.31 | N/A |
| Revenue | ★ $1,222,932,000.00 | $642,269,000.00 |
| Revenue This Year | $9.56 | $9.75 |
| Revenue Next Year | $7.08 | $5.62 |
| P/E Ratio | $12.10 | ★ N/A |
| Revenue Growth | 10.17 | ★ 11.17 |
| 52 Week Low | $11.17 | $10.70 |
| 52 Week High | $40.95 | $34.13 |
| Indicator | GCT | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 64.11 | 48.43 |
| Support Level | $37.88 | $10.79 |
| Resistance Level | $40.95 | $13.94 |
| Average True Range (ATR) | 1.71 | 0.65 |
| MACD | -0.15 | 0.09 |
| Stochastic Oscillator | 78.81 | 48.41 |
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.